Learning Objectives:
1. Recognize and assess patients at high-risk for an underlying cancer predisposition syndrome
2. Incorporate evidence-based cancer risk management, prevention, and targeted therapies in clinical practice
3. Perform psychosocial assessment in the high-risk setting
Session date:
07/09/2024 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Feighanne Hathaway, MS LCGC Emma Keel, MS LCGC Christine Drogan, MS LCGC Robin Bradley, MS CGC